AI Cures Cancer or Cuts 300M Jobs? O'Leary vs. Altman Flip
Tech cheerleaders tout productivity miracles while AI bosses and Goldman warn of sudden labor collapse.
Kevin O'Leary pushes AI as education and health accelerator. Meanwhile Dario Amodei, Sam Altman and Goldman Sachs flag mass displacement. Both sides cite the same models yet reach opposite conclusions on timing and scale.
Why these scores — Real quotes from named executives and a bank report. Some amplification from podcast clips and quote tweets, but core claims track public statements without heavy bot distortion.
Goldman Sachs pegged 300 million jobs at risk from generative AI while Kevin O'Leary claims the same tools will help cure cancer and teach every kid on Earth.
Side A points to measurable output gains in coding and drug discovery. Side B tracks executive comments from 2023 to 2025 that quietly shifted from "no jobs lost" to "many roles change fast." Both cite the same papers.
The fight stays loud because neither camp shows hard longitudinal data on net employment yet. Rhetoric runs ahead of the employment numbers that would settle it.
AI lifts output in research and education, creates new roles, and accelerates discovery in medicine and materials.
- @kevinolearytv✓ verified“AI will help cure cancer, democratize education and add productivity.”
Current AI wave targets cognitive work at scale, with Altman and Amodei now acknowledging rapid job churn Goldman models as structural unemployment.
- @theallinpod✓ verified“Dario and Altman flip rhetoric on AI jobs while Goldman warns of apocalypse.”